[1] Asahara T,Marohara T,Sullivan A,et al.Isolation of putative progenitor en-dothelial cells for angiogenesis. Science. 1997; 275(5302):964-967.[2] Murohara T,Ikeda H,Duan J.Transplanted cord blood.derived endothelial progenitor cells augment postnatal neovascularization.J Clin Invest.2000; 105(11): 1527-1536.[3] Liu F, Liu ZD, Wu N, et al.In vitro interactions between rat bone marrow-derived endothelial progenitor cells and hepatic stellate cells: Interaction between EPCs and HSCs. In Vitro Cellular & Developmental Biology.2013; 49(7):537-547.[4] Goligorsky MS, Salven P.Concise Review: Endothelial Stem and Progenitor Cells and Their Habitats. Stem Cells Transl Med. 2013; 2(7): 499-504.[5] Flammer AJ,Gössl M,Widmer RJ.Osteocalcin positive CD133+/CD34-/KDR+ pro-genitor cells as an independent marker for unstable atherosclerosis. Eur heart. 2012; 33(23):2963-2969.[6] Hur J,Yoon CH,Kim HS,et al.Characterization of two types of ndothelial progenitor,cells and their different contribution to neovasculogenesis. Arte-rioscler Titromb Vusc Biol. 2004; 24(2):288-293.[7] Kong D,Melo LG,Mangi AA,et al.Enhanced inhibition of neointimal hyperpla-sia by genetically engineered endothelial progenitor cells. Circulation.2004; 1(9):1769-1775.[8] Davidoff AM, Ng CY, Brown P, et al.Bone Marrow-derived Cells Contribute to Tumor Neovasculature and, When Modified to Express an Angiogenesis Inhibi-tor, Can Restrict Tumor Growth in Mice. Clin Cancer Res.2001; 7(9):2870-2879.[9] Taguchi A, Soma T, Tanaka H, et al.Administration of CD34+cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest. 2004; 1(14):330-338.[10] Willing Ar, Lixian J, Milliken M, et al.Intravenous versus intrastriatal cord blood administration in arodent model of stroke.Neurosci Res. 2003; 73:296-307.[11] Huang WJ,Xiao FY, Zhang HQ. Effects of endothelial progenitor cells and endothelial outgrowth cells in repair of injured carotid vessel: A comparative study with rabbits. Zhonghua Yi Xue Za Zhi.2007;87:3143-3147[12] Wang CH, Verma S, Hsieh IC,et al.Enalapril increases ischemia-inducedendothelial progenitor cell mobilization,through manipulation of the cd26 system.J Mol Cell Cardiol. 2006;41(1): 34-43[13] Lapergue B.Mohammad A,et al.Endothlial progenitor,cells and cerebrovasular diseases.ProgNeurobiol.2007,83:349-362[14] Molyneux A, Kerr R, Stratton I, et al. International subarachnoid aneu-rysm trial(isat)of neurosurgical clipping VerSUS endovascular coiling in 2143 patients with ruptured intracranial aneurysms: A randomized trial. Lancet. 2002; 360: 1267-1274.[15] Schatteman GC,Dunnwald M,Jiao CH.Biology of bone marrow-derived endothe-lial cellprecursors. Am J Physiol- Heart C. 2007; 292(1): 1-18.[16] Jamous MA, Nagahiro S, Kitazato KL, et al.Vascular corrosion casts mir-roring early morphO1ogical changes that lead to the formation of saccular cerebral aneurysm: an experimental study in rats. Neurosurg. 2005; 102:532-535..[17] 徐勇, 张建宁. 外周血内皮祖细胞数量变化与颅内动脉瘤的生成[J]. 中国组织工程研究与临床康复,2011,15(6):1083-1087.[18] Wei HJ, Wang D, Chen JL, et al.Mobilization of circulating endothelial progenitor cells after endova scular the rapy for ruptured cerebral aneurysms. Neurosci Lett. 2011;498: 114-118.[19] Wei HJ, Mao Q, Liu L, et al.Changes and function of circulating endothe-lial progenitor cells in patients with cerebral aneurysm. Neurosci Res. 2011; 89:1822-1828.[20] Xu Y, Tian Y, Wei HJ, et al. Erythropoietin increases circulating endo-thelial progenitor cells and reduces the formation and progression ofcerebral aneurysm in rats. Neuroscience. 2011; 181:292-299[21] 封灏, 赵瑞, 方兴根, 等. 未破裂颅内动脉瘤患者外周血内皮祖细胞数量的研究[J].中国神经外科疾病研究杂志,2012, 11(1): 4-7.[22] Liang C, Feng H, Deng BQ, et al.Decreased levels and function of circu-lating endothelial progenitor cells in unruptured intracranial saccular aneu-rysm patients. Neurol Sci. 2013; in press.[23] Fang X, Zhao R, Wang K,et al. Bone marrow-derived endothelial progenitor cells are involved in aneurysm repair in rabbits. Journal of Clinical Neuro-science. 2012; 19(9):1283- 1286.[24] Li ZF, Fang XG, Yang PF,et al.Endothelial progenitor cells contribute to neointima formation in rabbit elastase-induced aneurysm after flow diverter treatment.CNS Neurosci Ther. 2013;19(5):352-357.[25] lesauskaite V,Epostolato MC,Castagnini M,et al.Expression of matrix met-alloproteinases, their tissue inhibitors and osteoponin in the wall of tho-racic and abdominal aortas with dilatative pathology. Hum Pathal. 2006; 37(8):1076-1084.[26] Eizawa T, Ikeda U, Murakami Y, et al.Increase in circulating endothelial progenitor cells after aortic aneurysm repair. Heart Vessels. 2004; 19:107-110.[27] WRITING GROUP MEMBERS, Lloyd-Jones D, Adams RJ,et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association.Circulation. 2010;121(7): e46-e215..[28] Yoshimura K, Aoki H, Ikeda Y, et al.Regression of abdominal aortic aneu-rysm by inhibition of c-Jun N-terminal kinase.Nat Med.2005; 11:1330-1338.[29] Davies MJ.Aortic aneurysm formation: lessons from human studies and ex-perimental models. Circulation. 1998; 98: 193-195.[30] Freestone T,Turner RJ,Coady A,et al.Inflammation and matrix metallopro-teinases in the enlarging abdominal aortic aneurysm.Arterioscler Thromb Vasc Biol. 1995; 15:1145- 1151.[31] Touat Z, Ollivier V,Dai J,et al.Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution.Am J Pathol. 2006; 168:1022-1030.[32] Sung SH, Wu TC, Chen JS, et al.Reduced number and impaired function of circulating endothelial progenitor cells in patients with abdominal aortic an-eurysm. Int J Cardiol. 2013 p 30;168(2):1070-1077. [33] Van Spyk EN, Chun KC, Samadzadeh KM, et al.Increased levels of CD34+ cells are associated in patients with abdominal aortic aneurysms compared with patients with peripheral vascular disease. J Surg Res. 2013;184(1): 638-643.[34] Dawson J, Tooze J, Cockerill G, et al.Endothelial Progenitor Cells and Abdominal Aortic Aneurysms. Ann N Y Acad Sci. 2006;1085:327-330.[35] 毛梅,张波,傅祖红,等. 内皮祖细胞移植对肺损伤炎症状态的影响[J]. 中国组织工程研究,2013,17(10):1780-1784. [36] 杨震,夏文豪,罗初凡,等. 高血压循环内皮祖细胞变化和动脉弹性的关系[J]. 中山大学学报:医学科学版,2012,33(1):54-59. [37] 方唯一,张敏. 内皮祖细胞在经皮冠状动脉介入治疗后内皮损伤修复中的作用[J]. 上海交通大学学报:医学版,2011,31(3): 256-260. [38] 刘力,康熙雄. 循环血管内皮祖细胞对血管修复作用的研究进展[J]. 基础医学与临床,2011,31(9):1057-1059. [39] 李桂琼,陈庆伟. 内皮祖细胞移植策略研究进展[J]. 心血管病学进展,2011,32(3): 411-414. [40] 张晓蕾. 内皮祖细胞信号通路调控[J]. 中国动脉硬化杂志,2010, 18(10):837-840.[41] 姜靖,黄岚,赵晓辉,等. Klotho对老龄小鼠内皮祖细胞修复损伤血管内膜的影响[J]. 中国药业,2009,34(24):1114-1122. [42] 尹扬光,黄岚,赵晓辉,等. 基质细胞衍生因子1α参与血管损伤后内皮祖细胞动员及再内皮化[J]. 中华高血压杂志,2008,16(10): 928-932. [43] 周音频,黄岚,宋耀明,等. 粒细胞集落刺激因子动员骨髓内皮祖细胞促进损伤血管内皮修复[J]. 中国动脉硬化杂志,2008,16(3): 169-172. [44] 赵瑛,徐志玲,蔡绍皙. 内皮祖细胞在血管组织工程的应用[J]. 生物医学工程学杂志,2008,25(2):476-478. [45] 周志文,石蓓. 内皮祖细胞防治血管形成术后再狭窄研究进展[J]. 中国心血管病研究杂志,2007,5(5):387-390.[46] 崔斌,黄岚,武晓静,等. 内皮祖细胞移植对血管内膜修复的影响[J]. 中国病理生理杂志,2007,23(4):625-628. [47] 尹扬光,黄岚,赵晓辉,等. 基质细胞衍生因子1α介导小鼠内皮祖细胞修复损伤血管内膜[J]. 中国动脉硬化杂志,2007,15(1): 6-10. [48] 邹楠,王硕. 内皮祖细胞在相关脑血管疾病中的研究进展[J]. 中国卒中杂志,2012,7(12):973-978. |